Wednesday, 21 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14691
Articles
Company
Policy / Regulatory
Wuxi Biologics Set to Be Removed from US Restricted Trade List
March 2, 2025
Policy / Regulatory
R&D
CDE Releases 60th Batch of Chemical Generic Reference Preparations
March 2, 2025
Company
Deals
Beijing Tianshi Tongda Raises RMB 140M for Autoimmune Disease Therapies
March 3, 2025
Company
Deals
Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development
March 2, 2025
Company
Deals
Shandong Xinhua Pharmaceutical Inks Tech Transfer Deal for LXH-2201 with IMM
March 2, 2025
Drug
Shionogi Files NDA for S-217622 COVID-19 Antiviral Drug in China
March 3, 2025
Company
Drug
InnoCare Pharma’s ICP-490 Receives NMPA Approval for Hematological Malignancies
March 3, 2025
Company
Drug
Hrain Biotech and Novartis Receive Breakthrough Therapy Designations for CAR-T and Zolgensma
March 3, 2025
Company
Deals
Techbank Medical Closes RMB 100M Series A to Build Global Innovation Platform
March 3, 2025
Company
Deals
PackGene and Genemagic Partner on AAV Production and CDMO Services
March 3, 2025
Company
Drug
PersonGen BioTherapeutics’ TAA06 Receives Clinical Trial Approval for B7-H3 CAR-T Therapy
March 3, 2025
Company
Drug
Akeso Biopharma’s Cadonilimab Achieves National Delivery in China
March 3, 2025
1
2
…
1,204
1,205
1,206
1,207
1,208
…
1,224
1,225
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?